Burns, PA
Carol A. Burns, Wayne, PA US
Patent application number | Description | Published |
---|---|---|
20100324589 | EMBOLIC DEFLECTION DEVICE - There is disclosed a porous emboli deflector for preventing cerebral emboli while maintaining cerebral blood flow during an endovascular or open surgical procedure. The device prevents the entrance of emboli of a size able to cause stroke (such as greater than 100 microns) from entering either the right or left common carotid arteries, and/or the right or left vertebral arteries by deflecting emboli downstream of these vessels. The device can be placed prior to any manipulation of the heart or aorta allowing maximal protection of the brain during the index procedure. The deflector has a low profile within the aorta which allows sheaths, catheters, or wires used in the index procedure to pass. The deflector shaft could have a first portion and a second portion, the second portion being more flexible than the first portion. The deflector frame can include one, two, or more movable structures, such as hinges. Also disclosed are methods for insertion and removal of the deflector. | 12-23-2010 |
Christopher J. Burns, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20130233924 | Smartcard and Computer Quick Connect and Release System - A smartcard unit includes at least a smartcard and an attachment enabling the smartcard unit to be worn by a user. The smartcard is accessible to an external reader. A reader unit interfaces with the smartcard to enable an external computer to communicate with the smartcard. The smartcard unit or the reader unit has structure to align the reader unit relative to the smartcard unit in an alignment for communicative interfacing while the smartcard unit is being worn. The smartcard unit or the reader unit has a retainer to secure the reader unit in alignment relative to the smartcard so that the smartcard unit is reversibly separable from the reader unit without damage, in response to a force less than is necessary to detach or damage another part of said system, other than along a longitudinal axis of the smartcard or of a pair of components being separated. | 09-12-2013 |
20150356325 | Smartcard and Computer Quick Connect and Release System - A smartcard unit includes at least a smartcard and an attachment enabling the smartcard unit to be worn by a user. The smartcard is accessible to an external reader. A reader unit interfaces with the smartcard to enable an external computer to communicate with the smartcard. The smartcard unit or the reader unit has structure to align the reader unit relative to the smartcard unit in an alignment for communicative interfacing while the smartcard unit is being worn. The smartcard unit or the reader unit has a retainer to secure the reader unit in alignment relative to the smartcard so that the smartcard unit is reversibly separable from the reader unit without damage, in response to a force less than is necessary to detach or damage another part of said system, other than along a longitudinal axis of the smartcard or of a pair of components being separated. | 12-10-2015 |
Christopher J. Burns, Malvern, PA US
Patent application number | Description | Published |
---|---|---|
20090281336 | BENZOFURAN COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF HEPATITIS C VIRAL INFECTIONS AND ASSOCIATED DISEASES - The present invention relates to novel benzofuran derivatives and analogs, as well as compositions containing the same and to the use thereof for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases caused by the hepatitis C virus. | 11-12-2009 |
20100120715 | BETA-LACTAMASE INHIBITORS - Disclosed herein are α-aminoboronic acids and their derivatives which act as inhibitors of beta-lactamases. Also disclosed herein are pharmaceutical compositions comprising α-aminoboronic acids and methods of use thereof. | 05-13-2010 |
20100286092 | BETA-LACTAMASE INHIBITORS - Disclosed herein are α-aminoboronic acids and their derivatives which act as inhibitors of beta-lactamases. Also disclosed herein are pharmaceutical compositions comprising α-aminoboronic acids and methods of use thereof. | 11-11-2010 |
20100292185 | BETA-LACTAMASE INHIBITORS - Disclosed herein are α-aminoboronic acids and their derivatives which act as inhibitors of beta-lactamases. Also disclosed herein are pharmaceutical compositions comprising α-aminoboronic acids and methods of use thereof. | 11-18-2010 |
20100317621 | BETA-LACTAMASE INHIBITORS - Disclosed herein are α-aminoboronic acids and their derivatives which act as inhibitors of beta-lactamases. Also disclosed herein are pharmaceutical compositions comprising α-aminoboronic acids and methods of use thereof. | 12-16-2010 |
20110305666 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRUS INFECTION AND ASSOCIATED DISEASES - Compounds, compositions and methods are provided for the prophylaxis and treatment of infections caused by viruses of the Pneumovirinae subfamily of Paramyxoviridae and diseases associated with such infections. | 12-15-2011 |
20120183498 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRUS INFECTION AND ASSOCIATED DISEASES - Compounds, compositions and methods are provided for the prophylaxis and treatment of infections caused by viruses of the Pneumovirinae subfamily of Paramyxoviridae and diseases associated with such infection. | 07-19-2012 |
20140072532 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRUS INFECTION AND ASSOCIATED DISEASES - Compounds, compositions and methods are provided for the prophylaxis and treatment of infections caused by viruses of the Pneumovirinae subfamily of Paramyxoviridae and diseases associated with such infection. | 03-13-2014 |
20140171390 | BETA-LACTAMASE INHIBITORS - Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections. | 06-19-2014 |
20140194386 | BETA-LACTAMASE INHIBITORS - Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections. | 07-10-2014 |
20140363395 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRUS INFECTION AND ASSOCIATED DISEASES - Compounds, compositions and methods are provided for the prophylaxis and treatment of infections caused by viruses of the Pneumovirinae subfamily of Paramyxoviridae and diseases associated with such infection. | 12-11-2014 |
20150224125 | BETA-LACTAMASE INHIBITORS - Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections. | 08-13-2015 |
20150291630 | BETA-LACTAMASE INHIBITORS - Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections. | 10-15-2015 |
20150361106 | BETA-LACTAMASE INHIBITORS - Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections. | 12-17-2015 |
20150361108 | ORALLY BIOAVAILABLE BETA-LACTAMASE INHIBITORS - Described herein are compounds and compositions that modulate the activity of beta-lactamases and methods thereof. In some embodiments, the compounds described herein are biologically hydrolyzed to a beta-lactamase inhibitor. In certain embodiments, the compounds described herein are useful for the treatment of bacterial infections. | 12-17-2015 |
David Burns, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20110224189 | SUBSTITUTED CYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES - The present invention provides compounds of the formula: | 09-15-2011 |
David Burns, Glen Mills, PA US
Patent application number | Description | Published |
---|---|---|
20150225411 | AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS - The present invention provides azetidinyl phenyl, pyridyl, or pyrazinyl carboxamide derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase (JAKs) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases. | 08-13-2015 |
David M. Burns, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20090291946 | LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS - The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess. | 11-26-2009 |
20110136781 | IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS - The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways. | 06-09-2011 |
20120122858 | LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS - The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess. | 05-17-2012 |
20130018034 | AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS - The present invention provides azetidinyl phenyl, pyridyl, or pyrazinyl carboxamide derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase (JAKs) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases. | 01-17-2013 |
20130324515 | IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS - The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways. | 12-05-2013 |
David M. Burns, Glen Mills, PA US
Patent application number | Description | Published |
---|---|---|
20140171409 | AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS - The present invention provides azetidinyl phenyl, pyridyl, or pyrazinyl carboxamide derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase (JAKs) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases. | 06-19-2014 |
20140200216 | BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS - The present disclosure describes bicyclic aromatic carboxamide derivatives, as well as their compositions and methods of use. The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases. | 07-17-2014 |
20150025056 | SUBSTITUTED CYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES - The present invention provides compounds of the formula I: | 01-22-2015 |
20150057265 | FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS - The present disclosure describes furo- and thieno-pyridine carboxamide compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases. | 02-26-2015 |
Frank R. Burns, Media, PA US
Patent application number | Description | Published |
---|---|---|
20130274458 | GENETIC FINGERPRINTING AND IDENTIFICATION METHOD - The present disclosure provides methods for molecular fingerprinting for the characterization and identification of organisms. More specifically, in one aspect the present invention provides a method of identifying an organism in a sample comprising: (a) providing a sample comprising said organism, said organism comprising at least one nucleic acid; (b) combining said sample or the at least one nucleic acid therefrom with an amplification mix comprising at least one labeled oligonucleotide primer; (c) generating at least one labeled amplification product from the at least one nucleic acid of said organism using a nucleotide amplification technique employing said at least one labeled oligonucleotide primer; (d) combining said at least one labeled amplification product with products of a DNA sequencing reaction to create a separation mix; and (e) separating said separation mix on the basis of oligonucleotide length in a fluorescent DNA sequencing instrument to generate a sequence embedded fingerprint pattern for said organism. | 10-17-2013 |
Frank R. Burns, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20090042189 | Increased sensitivity of nucleic acid-based detection of organisms by fractionation of target genomes - A method of analyzing a sample for detection of presence or absence of an organism of interest in the sample comprising (a) obtaining a sample; (b) subjecting the sample to a disruption treatment sufficient to fractionate any nucleic acid sequences present in the sample; and (c) detecting for presence or absence of an organism of interest in the sample. The detecting step (c) may comprise performing primer-directed amplification (preferably polymerase chain reaction) on the sample to produce an amplification result and analyzing the amplification result for an amplification product, wherein presence or absence of the amplification product is indicative of the presence or absence of the organism of interest in the sample. | 02-12-2009 |
20090068647 | Dna sequences for the detection of and differentiation amongst pathogenic e.coli - Oligonucleotide sequences and methods for specifically detecting and differentiating amongst pathogenic | 03-12-2009 |
20110020823 | SEQUENCES AND THEIR USE FOR DETECTION AND CHARACTERIZATION OF E. COLI O157:H7 - This invention relates to a rapid method for detection and characterization of | 01-27-2011 |
20110045478 | Genetic Fingerprinting And Identification Method - The present disclosure provides methods for molecular fingerprinting for the characterization and identification of organisms. More specifically, in one aspect the present invention provides a method of identifying an organism in a sample comprising: (a) providing a sample comprising said organism, said organism comprising at least one nucleic acid; (b) combining said sample or the at least one nucleic acid therefrom with an amplification mix comprising at least one labeled oligonucleotide primer; (c) generating at least one labeled amplification product from the at least one nucleic acid of said organism using a nucleotide amplification technique employing said at least one labeled oligonucleotide primer; (d) combining said at least one labeled amplification product with products of a DNA sequencing reaction to create a separation mix; and (e) separating said separation mix on the basis of oligonucleotide length in a fluorescent DNA sequencing instrument to generate a sequence embedded fingerprint pattern for said organism. | 02-24-2011 |
20110104672 | Method For Detection And/Or Analysis Of Yeast And Mold In Filterable Liquids - This invention is an improved process for preparing a food or beverage sample containing yeast or mold cells for analytical testing. The food sample is prepared into the form of a filterable liquid, and then filtered using a glass microfiber filter. The filter containing the fungal cell retentate is then placed into a disruption vessel and bead beaten until the glass microfiber filter is completely disrupted into glass fibers in suspension. An aliquot can then be tested directly using melting curve analysis of PCR amplification product derived from the nucleic acids of the sample to detect the presence of the fungal cells from the sample. | 05-05-2011 |
20140371104 | SEQUENCES AND THEIR USE FOR DETECTION AND CHARACTERIZATION OF E. COLI 0157:H7 - This invention relates to a rapid method for detection and characterization of | 12-18-2014 |
20140371441 | SEQUENCES AND THEIR USE FOR DETECTION AND CHARACTERIZATION OF E. COLI 0157:H7 - This invention relates to a rapid method for detection and characterization of | 12-18-2014 |
H. Donald Burns, Harlysville, PA US
Patent application number | Description | Published |
---|---|---|
20090269278 | Radiolabeled Glycine Trasporter Inhibitors - The present invention is directed to radiolabeled glycine transporter inhibitors which are useful for the labeling and diagnostic imaging of glycine transporters in mammals. | 10-29-2009 |
Jason E. Burns, York, PA US
Patent application number | Description | Published |
---|---|---|
20120074619 | BLOW NEEDLE FOR EXTRUSION BLOW MOLDING PET - The present invention relates to a hollow blow needle for introducing a pressurized fluid into an extruded parison enclosed by two mold halves, the needle comprising: a body portion having an inner first diameter; a neck portion having an inner second diameter, wherein the inner second diameter is less than the inner first diameter; and a tip portion comprising a first angled portion, a second angled portion that is a different angle relative to the first angled portion, and an orifice. | 03-29-2012 |
Jennifer Burns, Spring City, PA US
Patent application number | Description | Published |
---|---|---|
20100247540 | Methods and Compositions For Modulating Angiogenesis - The present invention provides method and compositions for modulating angiogenesis. | 09-30-2010 |
Jennifer M. Burns, Royersford, PA US
Patent application number | Description | Published |
---|---|---|
20090054630 | Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors - Antibodies that bind CCX-CKR2 are described. | 02-26-2009 |
20110052589 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DISEASES AND CONDITIONS RELATED TO CHEMOKINE RECEPTORS - Ligands of CCX-CKR2 and the biological role of CCX-CKR2 in cancer is described. | 03-03-2011 |
20110165164 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DISEASES AND CONDITIONS RELATED TO CHEMOKINE RECEPTORS - Ligands of CCX-CKR2 and the biological role of CCX-CKR2 in cancer is described. | 07-07-2011 |
John H. Burns, Gap, PA US
Patent application number | Description | Published |
---|---|---|
20100152347 | TITANIUM AND ZIRCONIUM MIXTURES AND EMULSIONS FOR USE IN PREPARING GYPSUM WALLBOARD - Provided herein are mixtures, emulsions and other additives for use in manufacturing gypsum wallboard. The mixtures and emulsions may be wax-based emulsions or wax-free mixtures or emulsions, with wax-based emulsions including water, at least one wax, a dispersant which may include sulfur or a sulfur-containing group, and an additive comprising an organic titanium compound or organic zirconium compound. Mixtures may also be prepared including water, a dispersant; and an additive comprising an organic titanium compound or organic zirconium compound. Gypsum slurries may be prepared using such emulsions and mixtures and/or through addition of an organic titanium compound or organic zirconium compound. | 06-17-2010 |
John Hartley Burns, Gap, PA US
Patent application number | Description | Published |
---|---|---|
20100116406 | Wax Emulsion for Use in Building Products - Provided herein are an aqueous wax emulsion, comprising water; a paraffinic hydrocarbon; polyvinyl alcohol and a wax component comprising synthetic olefin wax component. The synthetic olefin wax component may be selected from the group consisting of (i) a synthetic normal α-olefin wax; (ii) a synthetic olefin wax of a carbon chain length of about 20 or more carbon atoms, that is modified by oxidizing and/or by refining through distillation or stripping; and (iii) combinations thereof. Such emulsions are also useful for and disclosed herein are settable gypsum compositions and water-resistant wallboard formed therefrom. Also included herein is a montan wax substitute for use in an aqueous montan-based wax emulsion having paraffinic hydrocarbon, a wax component, water and polyvinyl alcohol wherein the wax component includes the montan wax substitute in place of use of a montan wax in the wax component such that the montan wax substitute is about 1 part to about 100 percent of the wax component and includes a synthetic olefin wax. | 05-13-2010 |
20120263963 | WAX EMULSION FOR USE IN BUILDING PRODUCTS - Provided herein is an aqueous wax emulsion, comprising water; a paraffinic hydrocarbon; polyvinyl alcohol and a wax component comprising synthetic olefin wax component. The synthetic olefin wax component may be selected from the group consisting of (i) a synthetic normal α-olefin wax; (ii) a synthetic olefin wax of a carbon chain length of about 20 or more carbon atoms, that is modified by oxidizing and/or by refining through distillation or stripping; and (iii) combinations thereof. Such emulsions are also useful for settable gypsum compositions and water-resistant wallboard formed therefrom. Also included herein is a montan wax substitute for use in an aqueous montan-based wax emulsion. | 10-18-2012 |
Joseph Burns, Landenberg, PA US
Patent application number | Description | Published |
---|---|---|
20120178071 | Mobile Observation Panel - An apparatus for visually isolating an observer from an observed individual comprises a two way mirror forming a first panel and a movable frame disposed to hold the first panel in a vertical orientation; methods of assembling and operating instructional simulation lab, methods for instruction/proctoring/operating/repurposing a nursing simulation lab comprising the steps of identifying a space having a simulated patient location and an observation location, providing a panel assembly having a two way mirror, locating the panel assembly between the simulated patient location and the observation location, providing a patent simulation system including a simulated patient, providing a lab student, providing a lab instructor and/or observer, administering care to the simulated patient at the simulated patient location, and observing the administration of care at the observation location by looking towards the simulated patient location through the two way mirror. | 07-12-2012 |
Kathleen Burns, Doylestown, PA US
Patent application number | Description | Published |
---|---|---|
20090290789 | METHOD AND APPARATUS FOR REDUCED COMPLEXITY VIDEO PROCESSING VIA SPECIAL CHROMA HANDLING - A method and apparatus for reduced complexity video and image processing with special chroma handling are disclosed. Frame-type decisions are made on a video stream made up of a sequence of frames. A first subset of the frames are selected to be monochrome and generated without chroma data. A second subset of the frames are selected to be in color and generated with chroma components. In one embodiment, the first subset of frames includes odd frames and the second subset of frames includes even frames in the video stream. Under higher video frame rates, the lack of color in every other frame is not visible to the end viewer. Accordingly, subsequent processing of the output video stream permits luma-only processing of many frames in the video stream, extensively reducing the amount of computation. | 11-26-2009 |
Michael C. Burns, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20140107085 | Bifunctional AKR1C3 Inhibitors/Androgen Receptor Modulators and Methods of Use Thereof - The invention includes compositions comprising selective AKR1C3 inhibitors. The invention also includes compositions comprising bifunctional AKR1C3 inhibitors and selective androgen receptor modulators. The invention further includes methods of treatment using the compositions of the invention. | 04-17-2014 |
Michael F. Burns, Sewickley, PA US
Patent application number | Description | Published |
---|---|---|
20090037348 | Method of calculating and displaying premium freight costs - Methods for calculating and displaying premium freight costs are provided. The methods comprise the steps of: A) selecting a time period of interest; B) selecting all shipments occurring within the selected time period and indexing the shipments into a list; C) for each shipment in the list, evaluating whether the shipment was delivered in the optimal mode, optimal source, and/or optimal carrier, and if a non-optimal mode, source or carrier was used, calculating premium freight cost; D) if the premium freight cost is not negative, adding the premium freight cost to a lane for the non-optimal mode; and E) displaying the premium freight cost by lane on a computer screen. Information for carrying out the methods of the present invention is contained in various databases containing shipment data and optimality tables. | 02-05-2009 |
Morgan C. Burns, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20100304397 | Chromogenic test kit for detecting health conditions in saliva - A device and method for detecting diseases, disorders and health conditions in saliva or other body fluid. The method employs solid phase immunoassay and similar detecting processes along with one of several bioluminescent reactions such that the presence of specific biomarkers is reported visually on a chromogenic panel incorporated directly into the test kit. The device does not require electricity or refrigeration, and results in a small, sealed diagnostic packet that can be safely discarded or stored as necessary. | 12-02-2010 |
Richard Burns, Yardley, PA US
Patent application number | Description | Published |
---|---|---|
20100068689 | System and method for computer based creation of tests formatted to facilitate computer based testing - A computer-based test creation system and method for generating test items. The test creation process includes creating items in electronic form and allowing access by a plurality of reviewers via a network. The reviewers may review the item for content, fairness and format, and collaborate with each other before indicating that the item is acceptable for inclusion in a test. After the administration of the items to test takers, item performance may be evaluated on-line by reviewing electronic feedback from the administrations and creating electronic evaluation reports. Since the items are created in an electronic form, the items may further include new forms of stimuli such as graphics and multimedia. | 03-18-2010 |
Robert S. Burns, New Wilmington, PA US
Patent application number | Description | Published |
---|---|---|
20100139194 | ROOF PANELING SYSTEM - A roof paneling system includes a roof panel comprising an open-cell inorganic foam. The foam can decrease hydraulic conductivity of the roof paneling system, filter rainwater falling on the roof, and reflect excess heat. The open-cell inorganic foam preferably comprises a ceramic or glass, and has a porosity of at least about 20%, a mean pore size less than about 10 mm, and a thickness of at least about 10 mm. The foam can include a hydrophilic compound that further decreases the hydraulic conductivity of the foam. Optionally, the foam can have a reflectivity of at least about 20%. | 06-10-2010 |
20130269806 | Vee Manifold - A manifold having a first side, a second side, a first channel extending from the first side to the second side, and a second channel extending from the first side to the second side is disclosed. The first channel and the second channel each define a linear longitudinal axis. In one embodiment, the first channel longitudinal axis and the second channel longitudinal axis are oblique to the first side and the second side of the manifold. The manifold of the present disclosure provides channels that can be easily cleaned and allow for an increased flow performance. | 10-17-2013 |
20140260231 | "Substance Dispensing System" - A substance dispensing system that includes a hydraulic drive system is disclosed. The hydraulic drive system includes a hydraulic valve having a variable pressure setting, the hydraulic valve operable between a closed position in which a hydraulic pump moves hydraulic fluid to a hydraulic cylinder and an open position in which the hydraulic pump moves the hydraulic fluid to a hydraulic reservoir. The substance dispensing system of the present disclosure provides a system that recirculates hydraulic fluid in a hydraulic drive system instead of recirculating a substance back to a container via a pump. The substance dispensing system of the present disclosure allows for precise, accurate, and instantaneous control of an external force in a substance dispensing system. | 09-18-2014 |
20140263440 | Container and Substance Dispensing System - A confinement structure and an actuation member that provides a system that allows for controllable deformation of a variety of containers are disclosed. In one embodiment, the system of the present disclosure provides for controllable deformation of a container such that a portion of the container acts as a wiping means to empty a substance from the container. A container that includes an indentation formed on a first end of the container and a container opening located at a second end of the container is also disclosed. In one embodiment, with the container deformed to a final position, the indentation fits inside the container opening to completely expel a substance from the container. | 09-18-2014 |
20150151324 | Substance Dispensing System - A substance dispensing system that includes a hydraulic drive system is disclosed. The hydraulic drive system includes a hydraulic valve having a variable pressure setting, the hydraulic valve operable between a closed position in which a hydraulic pump moves hydraulic fluid to a hydraulic cylinder and an open position in which the hydraulic pump moves the hydraulic fluid to a hydraulic reservoir. The substance dispensing system of the present disclosure provides a system that recirculates hydraulic fluid in a hydraulic drive system instead of recirculating a substance back to a container via a pump. The substance dispensing system of the present disclosure allows for precise, accurate, and instantaneous control of an external force in a substance dispensing system. | 06-04-2015 |
20150251206 | Coating Applicator and Coating Application System - A coating applicator that applies a coating or liquid to a variety of different substrates having different contoured surfaces is disclosed. A coating applicator of the present disclosure is able to reach, contact, and cover the entirety of a contoured substrate. In this manner, the coating applicator is able to transfer a coating to the entirety of the contoured substrate. | 09-10-2015 |
Samuel P. Burns, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20130274625 | SEIZURE DETECTION DEVICE AND SYSTEMS - A neurostimulation device includes a plurality of electrodes adapted to be electrically connected to a subject to receive multichannel electrical signals from the subject's brain, a multichannel seizure detection unit electrically connected to the plurality of electrical leads to receive the multichannel electrical signals, and a neurostimulation unit in communication with the multichannel seizure detection unit. The plurality of electrodes are at least three electrodes such that the multichannel electrical signals are at least three channels of electrical signals, and the multichannel seizure detection unit detects a presence of a seizure based on multichannel statistics from the multichannel electrical signals including higher order combinations than two-channel combinations. | 10-17-2013 |
20140121554 | SEIZURE DETECTION DEVICE AND SYSTEMS - A neurostimulation device includes a plurality of electrodes adapted to be electrically connected to a subject to receive multichannel electrical signals from the subject's brain, a multichannel seizure detection unit electrically connected to the plurality of electrical leads to receive the multichannel electrical signals, and a neurostimulation unit in communication with the multichannel seizure detection unit. The plurality of electrodes are at least three electrodes such that the multichannel electrical signals are at least three channels of electrical signals, and the multichannel seizure detection unit detects a presence of a seizure based on multichannel statistics from the multichannel electrical signals including higher order combinations than two-channel combinations. Another embodiment of the invention includes determining a singular vector centrality (SVC) for each of the electrodes in order to detect the seizure onset. | 05-01-2014 |
Timothy Vincent Burns, Shavertown, PA US
Patent application number | Description | Published |
---|---|---|
20160002995 | INFLATABLE SEAL WITH FABRIC EXPANSION RESTRICTION - A diverter flowline seal assembly for use in subsea drilling. The seal assembly includes a seal body having an inner diameter end and an outer diameter end formed of an inflatable elastomeric material having a first modulus. The inner diameter end of the seal body includes two diametrically opposed axially inward lip portions and two diametrically opposed axially outward base portions. Integrated with the inflatable elastomeric material at the base portions of the inner diameter end of the seal body is a material having a modulus that is higher than the modulus of the inflatable elastomeric material so as to prevent the radial expansion of the lip portions and the base portions of the inner diameter end of the seal body. | 01-07-2016 |